Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
Clinical trial NCT06923826 · RECRUITING
Trial details
- NCT number
- NCT06923826
- Sponsor
- National University Hospital, Singapore
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2030-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.